L. Murray Et Al. , "Involved Node, Site, Field and Residual Volume Radiotherapy for Lymphoma: A Comparison of Organ at Risk Dosimetry and Second Malignancy Risks," Clinical Oncology , vol.27, no.7, pp.401-410, 2015
Murray, L. Et Al. 2015. Involved Node, Site, Field and Residual Volume Radiotherapy for Lymphoma: A Comparison of Organ at Risk Dosimetry and Second Malignancy Risks. Clinical Oncology , vol.27, no.7 , 401-410.
Murray, L., Sethugavalar, B., Robertshaw, H., Bayman, E., Thomas, E., Gilson, D., ... Prestwich, R.(2015). Involved Node, Site, Field and Residual Volume Radiotherapy for Lymphoma: A Comparison of Organ at Risk Dosimetry and Second Malignancy Risks. Clinical Oncology , vol.27, no.7, 401-410.
Murray, L. Et Al. "Involved Node, Site, Field and Residual Volume Radiotherapy for Lymphoma: A Comparison of Organ at Risk Dosimetry and Second Malignancy Risks," Clinical Oncology , vol.27, no.7, 401-410, 2015
Murray, L. Et Al. "Involved Node, Site, Field and Residual Volume Radiotherapy for Lymphoma: A Comparison of Organ at Risk Dosimetry and Second Malignancy Risks." Clinical Oncology , vol.27, no.7, pp.401-410, 2015
Murray, L. Et Al. (2015) . "Involved Node, Site, Field and Residual Volume Radiotherapy for Lymphoma: A Comparison of Organ at Risk Dosimetry and Second Malignancy Risks." Clinical Oncology , vol.27, no.7, pp.401-410.
@article{article, author={L. Murray Et Al. }, title={Involved Node, Site, Field and Residual Volume Radiotherapy for Lymphoma: A Comparison of Organ at Risk Dosimetry and Second Malignancy Risks}, journal={Clinical Oncology}, year=2015, pages={401-410} }